Skip to content
All lessons
Pulmonary · Pulmonary

Pulmonary Embolism & DVT

A boards-focused walkthrough of venous thromboembolism — from Virchow's triad and RV-strain pathophysiology through the Wells / D-dimer / CTPA diagnostic algorithm to next-best-step management, contrasting outpatient anticoagulation for low-risk PE with systemic thrombolysis for massive (high-risk) PE. Emphasizes classic vignette buzzwords and Step 1 / Step 2 CK decision points.

13 min readHigh yield

Pathophysiology: Clot to Collapse

Deep vein thrombosis (DVT) usually forms in the proximal deep veins of the leg (popliteal, femoral, iliac); proximal clots are the ones that embolize. A dislodged thrombus travels IVC → right heart → pulmonary arteries.

Virchow's triad drives clot formation: venous stasis, endothelial injury, and hypercoagulability.

Downstream effects of the lodged embolus:

  • The embolized segment is ventilated but no longer perfused → increased dead space (wasted ventilation, a high-V/Q zone). Blood diverts to the remaining lung → V/Q mismatch and shunt → hypoxemia, with compensatory hyperventilation → respiratory alkalosis (hypocapnia).
  • A large/saddle embolus acutely raises pulmonary vascular resistance → ↑ RV afterload → RV dilation/failure → obstructive shock and sudden death.
  • Pulmonary infarction is uncommon (~10%) because the lung has a dual supply (bronchial + pulmonary arteries); when it occurs it causes pleuritic pain and hemoptysis.
Risk Factors & Vignette Buzzwords
  • Virchow's triad: stasis · endothelial injury · hypercoagulability
  • Stasis: recent surgery, immobilization, long-haul flight, hospitalization, CHF
  • Hypercoagulable: Factor V Leiden (most common inherited), prothrombin G20210A, protein C/S or antithrombin deficiency, malignancy (Trousseau migratory thrombophlebitis), OCPs/pregnancy, nephrotic syndrome (urinary antithrombin III loss), antiphospholipid syndrome, HIT
  • Classic PE vignette: sudden dyspnea + pleuritic chest pain + tachycardia with clear lungs, days after surgery or a long flight
  • Most common symptom = dyspnea; most common sign = tachypnea (with tachycardia)
  • DVT: unilateral leg swelling, warmth, tenderness (Homan sign unreliable)
  • Massive PE: syncope, hypotension, JVD, loud P2, RV heave
Vignette: Which Test First?

Vignette: A 58-year-old woman has acute dyspnea and pleuritic chest pain 5 days after total knee replacement. HR 112, RR 24, SpO₂ 90%, lungs clear, BP 128/78 (stable).

Approach — patient is hemodynamically stable, so risk-stratify:

  1. Wells score. PE likely (>4) → go straight to CTPA (CT pulmonary angiography, the test of choice).
  2. PE unlikely (≤4) → D-dimer; negative rules out (high NPV), positive → CTPA.
  3. PERC rule can exclude PE in a patient already judged low-risk by gestalt — without even a D-dimer.

Here: PE is the leading diagnosis + recent surgery + tachycardia push Wells >4 → next best step = CTPA, not D-dimer (which would be non-specifically elevated post-op anyway).

If contrast is contraindicated (renal failure, contrast allergy) → V/Q scan.

Swollen, erythematous right lower leg characteristic of a deep vein thrombosis
Unilateral leg swelling, warmth, and redness — the classic DVT limb. · Wikimedia Commons — James Heilman, MD — CC BY-SA 3.0, via Wikimedia Commons
Diagnostic Findings
  • CTPA = confirmatory test of choice → intraluminal filling defect
  • Compression ultrasound = test of choice for DVT
  • D-dimer: very sensitive, poor specificity → only useful to rule OUT at low/intermediate pretest probability
  • ABG: hypoxemia, hypocapnia, respiratory alkalosis, widened A–a gradient
  • ECG: sinus tachycardia = most common; S1Q3T3 and new RBBB = RV strain (classic but uncommon)
  • CXR: usually normal; may show Hampton hump (wedge-shaped infarct), Westermark sign (focal oligemia), Fleischner sign (enlarged central pulmonary artery)
  • Troponin/BNP ↑ with RV dysfunction on echo (McConnell sign — RV free-wall hypokinesis with apical sparing) = submassive PE, worse prognosis
  • PFTs are not used for acute PE; chronic thromboembolic pulmonary hypertension (CTEPH) shows a reduced DLCO
CT pulmonary angiogram showing a saddle embolus — a large intraluminal filling defect occluding the main pulmonary arteries
CTPA: a saddle embolus — intraluminal filling defect occluding the main pulmonary arteries. CTPA is the confirmatory test of choice. · Wikimedia Commons — Rvahudson — CC BY-SA 4.0, via Wikimedia Commons

Risk Stratification Drives Treatment

CategoryHemodynamicsRV strain (troponin/BNP/echo)Management
Low-riskNormal BPAbsentAnticoagulation; consider outpatient if PESI low
Submassive (intermediate)NormotensivePresentAnticoagulate + admit/monitor; thrombolysis case-by-case
Massive (high-risk)SBP <90 / shockPresentThrombolysis (tPA); if contraindicated → catheter-directed therapy or embolectomy
Classic Memory Hooks
  • Virchow's triad (why clots form): Stasis · Hypercoagulability · Endothelial injury
  • S1Q3T3 (acute cor pulmonale on ECG): deep S in lead I, Q wave + inverted T in lead III = RV strain — classic, though sinus tachycardia is commoner
  • Wells scorePE likely vs unlikely decides CTPA vs D-dimer
  • Homan sign (calf pain on dorsiflexion): classically taught for DVT but insensitive and nonspecific — don't rely on it
Vignette: The Crashing Patient

Vignette: A 66-year-old man collapses hours after a 14-hour flight. BP 78/40, HR 130, JVD, SpO₂ 84%; bedside echo shows a dilated, hypokinetic RV (McConnell sign).

This is massive (high-risk) PE with obstructive shock. Next best step:

  1. Resuscitate: O₂, cautious IV fluids (aggressive volume worsens RV distension), vasopressors; start heparin.
  2. Systemic thrombolysis (alteplase/tPA) — the answer for hemodynamically unstable PE with no contraindication.
  3. If thrombolysis is contraindicated (active bleeding, recent stroke/surgery) or fails → catheter-directed thrombolysis or surgical embolectomy.

If the patient is too unstable to travel, treat empirically — don't wait for CTPA. Place an IVC filter only when anticoagulation is contraindicated or PE recurs despite adequate anticoagulation.

Anticoagulation: Picking the Agent

ScenarioPreferred agentKey point
Most stable patientsDOAC (apixaban, rivaroxaban)No routine monitoring; these two need no heparin bridge (unlike dabigatran/edoxaban)
Cancer-associatedDOAC or LMWHLMWH long the standard; caution with GI/GU tumors on DOAC (bleeding)
PregnancyLMWH (enoxaparin)Warfarin & DOACs contraindicated
Warfarin therapyWarfarin + heparin bridgeOverlap ≥5 d until INR 2–3; bridge covers transient protein C drop
HITArgatroban / bivalirudinStop all heparin; avoid warfarin until platelets recover
Duration & Loose Ends
  • Provoked by a transient/reversible factor (e.g., surgery) → 3 months
  • Unprovoked → at least 3 months, then reassess for extended/indefinite therapy
  • Recurrent VTE or active cancerindefinite anticoagulation
  • IVC filter: anticoagulation contraindicated (active bleeding) or recurrent PE despite therapeutic anticoagulation
  • Board look-alikes: fat embolism (long-bone fracture → dyspnea + petechiae + confusion), amniotic fluid embolism (labor → DIC + shock), air embolism
  • Prevention in hospitalized/post-op patients: early ambulation, LMWH prophylaxis, pneumatic compression

Practice Pulmonary now

Board-style questions, spaced-repetition flashcards, and a Socratic AI tutor — free to start.